FTC Is Fighting Pharma Tactics To Stall Investigations; Commission Goes To Court to Enforce Subpoenas
Executive Summary
The Federal Trade Commission has another beef with the pharmaceutical industry: It says there is a growing trend of companies refusing to cooperate with FTC probes
You may also be interested in...
Watson CEO Claims FTC Pressured Company To Allow Apotex To Market Generic Provigil
Watson CEO Paul Bisaro is fighting an FTC subpoena to testify in the commission's investigation of a reverse settlement agreement involving Cephalon's Provigil.
Watson CEO Claims FTC Pressured Company To Allow Apotex To Market Generic Provigil
Watson CEO Paul Bisaro is fighting an FTC subpoena to testify in the commission's investigation of a reverse settlement agreement involving Cephalon's Provigil.
FTC Sues Solvay, Watson, Parr, Paddock for Settlements to Delay Generic AndroGel
FTC continues to struggle to find a winning formula in challenges of “reverse payment” cases.